These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9225292)

  • 1. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.
    Lummis SC; Baker J
    Neuropharmacology; 1997; 36(4-5):665-70. PubMed ID: 9225292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
    Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
    Molderings GJ; Schmidt K; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorpromazine and QX222 block 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Sepúlveda MI; Baker J; Lummis SC
    Neuropharmacology; 1994; 33(3-4):493-9. PubMed ID: 7984288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
    Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
    Boess FG; Sepúlveda MI; Lummis SC; Martin IL
    Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ; West KE; Kilpatrick GJ; Barnes NM
    Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors.
    Cubeddu LX; Bönisch H; Göthert M; Molderings G; Racké K; Ramadori G; Miller KJ; Schwörer H
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):85-91. PubMed ID: 10651152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
    Niemeyer MI; Lummis SC
    Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D; Neijt HC
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.
    Hoyer D; Neijt HC; Karpf A
    J Recept Res; 1989; 9(1):65-79. PubMed ID: 2915346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
    Ito C; Isobe Y; Tsuchida K; Higuchi S
    Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranes.
    Hellevuo K; Hoffman PL; Tabakoff B
    Alcohol Clin Exp Res; 1991 Oct; 15(5):775-8. PubMed ID: 1755508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of detergents on binding of 5-hydroxytryptamine3 receptor antagonist [3H]GR65630 to rat cortical membranes.
    Inoue A; Tominaga Y; Nishio H; Segawa T; Nakata Y
    Neurochem Int; 1993 Jun; 22(6):547-53. PubMed ID: 8513282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM; Barnes NM
    Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.
    Lummis SC; Kilpatrick GJ; Martin IL
    Eur J Pharmacol; 1990 Sep; 189(2-3):223-7. PubMed ID: 2253704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric interactions among agonists and antagonists at 5-hydroxytryptamine3 receptors.
    Bonhaus DW; Stefanich E; Loury DN; Hsu SA; Eglen RM; Wong EH
    J Neurochem; 1995 Jul; 65(1):104-10. PubMed ID: 7790853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.